Ginkgo Bioworks Holdings (DNA) Treasury Shares (2021)

Ginkgo Bioworks Holdings (DNA) has 8 years of Treasury Shares data on file, last reported at $3.0 million in Q1 2026.

• Quarterly Treasury Shares fell 26.71% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 26.71% YoY) and the FY2025 annual result came in at $4.4 million, up 32.45% from the prior year.
• Treasury Shares retreated to $3.0 million in Q1 2026, from $4.4 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $238.7 million in Q1 2024 to a low of $564227.0 in Q4 2023.
• A 5-year average of $89.3 million and a median of $23.5 million in 2022 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares surged 615.15% — and 2025, when it plunged 98.28%.
• Tracing DNA's Treasury Shares over 5 years: stood at $23.5 million in 2022, then plunged by 97.6% to $564227.0 in 2023, then jumped by 489.73% to $3.3 million in 2024, then soared by 32.45% to $4.4 million in 2025, then slumped by 31.56% to $3.0 million in 2026.
• The last three Treasury Shares figures came in at $3.0 million (Q1 2026), $4.4 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.